成人、儿童和新生儿COVID-19心脏骤停患者的处理:美洲心脏病学会(SIAC)、墨西哥国家心脏病学家协会(ANCAM)和墨西哥心脏病学会(SMC)的建议
该建议由美洲心脏病学会(SIAC)、墨西哥国家心脏病学家协会(ANCAM)和墨西哥心脏病学会(SMC)制定,针对成人、儿童和新生儿COVID-19心脏骤停患者。COVID-19患者中高达15%为重症、5%为危重症,平均死亡率3%;高龄及高血压、心血管疾病、肥胖和糖尿病等合并症可使死亡率升至24%。院外心脏骤停病例近期增多,心脏骤停原因多为呼吸性而非心源性。是否启动或继续心肺复苏需权衡受害者生存可能性(迄今报道极低)与医护人员高感染风险。
要点
- COVID-19患者中高达15%为重症、5%为危重症,平均死亡率3%,因国家和患者基线特征而异。
- 高龄及高血压、心血管疾病、肥胖和糖尿病等合并症可使死亡率升至24%。
- 近期有院外心脏骤停病例增加的报道,心脏骤停多与呼吸性疾病相关而非心脏问题。
- 是否启动或继续心肺复苏须仔细评估,因迄今报道的生存率极低且医护人员感染风险高。
- 由于SARS-CoV-2传播率高,复苏操作需要对现有国际心肺复苏指南进行潜在修改。
适用人群与场景
- 成人、儿童和新生儿COVID-19心脏骤停患者。
- 院外心脏骤停(OHCA)病例近期有增加报道。
研究设计与关键结果
- 制定机构:美洲心脏病学会(SIAC)、墨西哥国家心脏病学家协会(ANCAM)和墨西哥心脏病学会(SMC)。
- COVID-19患者中高达15%有严重疾病,5%有危重感染形式,平均死亡率3%,但因报告国家和患者基线条件(包括年龄、动脉高血压、心血管疾病、糖尿病或肥胖)存在显著差异。
- 在这些高风险受试者中,死亡率可能高达24%。
- 有近期院外心脏骤停(OHCA)受害者增加的报道。
- 这些受试者的心脏骤停可能与多种原因有关,但显然该现象与呼吸性疾病相关而非心脏问题。
- 在此背景下,必须仔细评估启动或继续心肺复苏操作的决定,因为迄今报道的生存率低且医护人员感染风险高。
证据类型、等级与局限
- 证据类型:指南/共识(美洲心脏病学会、墨西哥国家心脏病学家协会和墨西哥心脏病学会的建议)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 由于SARS-CoV-2传播率高,复苏操作需要对现有国际心肺复苏指南进行潜在修改。
- 是否启动或继续心肺复苏须仔细评估,权衡受害者生存可能性(迄今报道极低)与医护人员高感染风险。
指南或共识出处
- 美洲心脏病学会(SIAC)、墨西哥国家心脏病学家协会(ANCAM)和墨西哥心脏病学会(SMC)建议,发表于Arch Cardiol Mex。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
La pandemia de COVID-19 ha infligido grandes estragos a la población y en especial al personal de salud. Los esfuerzos de reanimación exigen modificaciones potenciales de las guías internacionales existentes de reanimación cardiopulmonar (RCP) debido al elevado índice de contagiosidad del virus SARS-CoV-2. Se considera que hasta 15% de los casos de COVID-19 tiene una enfermedad grave y 5% padece un trastorno crítico con una mortalidad promedio del 3%, la cual varía según sean el país y las características de los pacientes. La edad y las comorbilidades como la hipertensión arterial, enfermedad cardiovascular, obesidad y diabetes incrementan la mortalidad hasta 24%. También se ha informado un aumento reciente del número de casos de paro cardíaco extrahospitalario (PCEH). Aunque el paro cardíaco (PC) puede ser efecto de factores diversos en estos pacientes, en la mayoría de los casos se ha demostrado que el origen es respiratorio, con muy pocos casos de causa cardíaca. Se debe considerar la indicación de iniciar o continuar las maniobras de RCP por dos razones fundamentales: la posibilidad de sobrevida de las víctimas, que hasta la fecha se ha registrado muy baja, y el riesgo de contagiar al personal de salud, que es muy alto. The COVID-19 pandemic is having a large impact on the general population, but it has taken a specially high toll on healthcare personnel. Resuscitation efforts require potential modifications of the present Cardiopulmonary Resuscitation (CPR) international guidelines because of the transmissibility rate of the new SARS-CoV 2 virus. It has been seen that up to 15% of COVID-19 patients have a severe disease, 5% have a critical form of infection and the mean death rate is 3%, although there are significant differences according to the country that reports it and patients’ baseline conditions that include age, presence of arterial hypertension, cardiovascular disease, diabetes or obesity. In these high risk subjects, mortality might go up to 24%. There are also reports of a recent increase in out-of-hospital cardiopulmonary arrest (OHCA) victims. Cardiac arrest (CA) in these subjects might be related to many causes, but apparently, that phenomenon is related to respiratory diseases rather than cardiac issues. In this context, the decision to start or continue CPR maneuvers has to be carefully assessed, because of the low survival rate reported so far and the high contagion risk among healthcare personnel.
The COVID-19 pandemic is having a large impact on the general population, but it has taken a specially high toll on healthcare personnel. Resuscitation efforts require potential modifications of the present Cardiopulmonary Resuscitation (CPR) international guidelines because of the transmissibility rate of the new SARS-CoV 2 virus. It has been seen that up to 15% of COVID-19 patients have a severe disease, 5% have a critical form of infection and the mean death rate is 3%, although there are significant differences according to the country that reports it and patients’ baseline conditions that include age, presence of arterial hypertension, cardiovascular disease, diabetes or obesity. In these high risk subjects, mortality might go up to 24%. There are also reports of a recent increase in out-of-hospital cardiopulmonary arrest (OHCA) victims. Cardiac arrest (CA) in these subjects might be related to many causes, but apparently, that phenomenon is related to respiratory diseases rather than cardiac issues. In this context, the decision to start or continue CPR maneuvers has to be carefully assessed, because of the low survival rate reported so far and the high contagion risk among healthcare personnel.
参考来源
- Rodríguez-Reyes H, Ortiz-Galván F, Ibarrola M, et al. Treatment of adult, child and newborn cardiac arrest victims with COVID-19. Recommendations from the Interamerican Society of Cardiology / Sociedad Interamericana de Cardiología (SIAC), Mexican National Cardiologists Association / Asociación Nacional de Cardiólogos de México (ANCAM) and Mexican Society of Cardiology / Sociedad Mexicana de Cardiología (SMC). Arch Cardiol Mex. 2021. PMID: 34968378. doi:10.24875/ACM.20000243
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。